Loading...
XJPX4272
Market cap1.27bUSD
Jan 20, Last price  
1,269.00JPY
1D
0.75%
1Q
5.53%
Jan 2017
-12.06%
Name

Nippon Kayaku Co Ltd

Chart & Performance

D1W1MN
XJPX:4272 chart
P/E
48.77
P/S
0.99
EPS
26.02
Div Yield, %
3.57%
Shrs. gr., 5y
-0.86%
Rev. gr., 5y
3.17%
Revenues
201.79b
+1.72%
134,205,000,000140,026,000,000148,124,000,000144,901,000,000134,344,000,000141,029,000,000148,897,000,000147,119,000,000154,368,640,402160,068,000,000161,857,000,000162,936,000,000159,112,000,000167,882,000,000172,640,000,000175,133,000,000173,384,000,000184,805,000,000198,380,000,000201,791,000,000
Net income
4.11b
-72.55%
5,315,000,0009,641,000,0006,610,000,0006,630,000,0003,718,000,0009,871,000,00013,004,000,00011,401,000,00014,538,664,47016,718,000,00015,653,000,00017,291,000,00015,635,000,00015,472,000,00014,851,000,00012,815,000,00012,574,000,00017,181,000,00014,984,000,0004,113,000,000
CFO
23.24b
+15.98%
12,160,000,00011,791,000,00020,201,000,00015,975,000,00018,037,000,00020,284,000,00018,969,000,00022,791,000,00017,334,000,00029,480,000,00020,263,000,00019,603,000,00031,390,000,00020,121,000,00026,803,000,00027,281,000,00024,408,000,00023,141,000,00020,039,000,00023,242,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 03, 2025

Profile

Nippon Kayaku Co., Ltd., together with its subsidiaries, develops, manufactures, and sells functional chemicals, pharmaceuticals, safety systems, and agrochemicals and other products in Japan and internationally. The company's Functional and Chemical Business segment offers functional materials, such as epoxy resins, UV-curable resins, sealants for LCD and LED, maleimide resins, photoresists and insulating materials for micro electromechanical systems, and cleaning agents and chemicals. This segment also provides color materials, including inkjet colorants, dyes for textiles and papers, and materials for thermal paper; catalysts for the production of acrylic and methacrylic acid; and polarizing films, inorganic polarizers, liquid crystal display components and projector parts, and components for x-ray analysis. Its Pharmaceuticals Business segment offers anti-cancer and cancer-related drugs, biosimilars, generic drugs, interventional radiology products, cardiovascular drugs, bulk drugs and intermediates of pharmaceuticals, and drugs for diagnosing cancer, as well as GlycoMark, a product as a marker of blood sugar control used for diabetes. The company's Safety Systems Business segment provides airbag inflators, micro gas generators for seatbelt pretensioners, and squibs. Its Agrochemicals Business segment offers agricultural insecticides, herbicides, soil fumigants, and insanitary insecticides. The company also engages in real estate leasing services. The company was formerly known as Nihon Kayaku Seizou Co., Ltd. and changed its name to Nippon Kayaku Co., Ltd. in 1945. Nippon Kayaku Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.
URL
https://www.nipponkayaku.co.jp/
IPO date
May 16, 1949
Employees
5,782
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
201,791,000
1.72%
198,380,000
7.35%
184,805,000
6.59%
Cost of revenue
194,454,000
190,205,000
176,789,000
Unusual Expense (Income)
NOPBT
7,337,000
8,175,000
8,016,000
NOPBT Margin
3.64%
4.12%
4.34%
Operating Taxes
3,026,000
5,929,000
6,455,000
Tax Rate
41.24%
72.53%
80.53%
NOPAT
4,311,000
2,246,000
1,561,000
Net income
4,113,000
-72.55%
14,984,000
-12.79%
17,181,000
36.64%
Dividends
(7,855,000)
(7,550,000)
(5,070,000)
Dividend yield
3.63%
3.76%
2.58%
Proceeds from repurchase of equity
(157,000)
6,112,000
(3,068,000)
BB yield
0.07%
-3.05%
1.56%
Debt
Debt current
13,450,000
3,380,000
7,176,000
Long-term debt
18,151,000
16,378,000
9,673,000
Deferred revenue
410,000
Other long-term liabilities
4,171,000
4,211,000
4,677,000
Net debt
(80,590,000)
(60,439,000)
(55,121,000)
Cash flow
Cash from operating activities
23,242,000
20,039,000
23,141,000
CAPEX
(15,829,000)
(12,987,000)
(9,467,000)
Cash from investing activities
(19,409,000)
(15,158,000)
(10,641,000)
Cash from financing activities
3,823,000
(7,950,000)
(11,090,000)
FCF
(1,206,000)
(10,360,000)
(7,257,000)
Balance
Cash
66,177,000
54,347,000
53,645,000
Long term investments
46,014,000
25,850,000
18,325,000
Excess cash
102,101,450
70,278,000
62,729,750
Stockholders' equity
260,119,000
244,743,000
233,287,000
Invested Capital
204,066,550
206,814,000
202,024,250
ROIC
2.10%
1.10%
0.79%
ROCE
2.32%
2.87%
2.93%
EV
Common stock shares outstanding
165,837
167,682
168,942
Price
1,306.00
9.11%
1,197.00
3.10%
1,161.00
8.61%
Market cap
216,583,122
7.91%
200,715,354
2.33%
196,141,662
7.43%
EV
136,980,122
141,284,354
141,965,662
EBITDA
21,739,000
22,415,000
22,115,000
EV/EBITDA
6.30
6.30
6.42
Interest
127,000
103,000
82,000
Interest/NOPBT
1.73%
1.26%
1.02%